Men diagnosed with nonmetastatic low- and intermediate-risk prostate cancer up to 6 times more likely to die of other causes.

Prostate cancer doesn’t shout. It creeps. Quietly. Persistently. And for men of African ancestry — whether in Nassau, Abuja, or New York — it creeps faster, earlier, and with deadlier ...

According to analysts at Vantage Market Research, the Global Prostate Specific Antigen (PSA) Testing Market size is worth USD ...

Prostate cancer is the most prevalent cancer in Australia. This article discusses the limitations of PSA tests in determining ...

Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85% ...

Prostate cancer is the most common cancer in Australian men, often detected through PSA blood tests. New guidelines suggest ...

Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of ...

A new research paper was published in Volume 16 of Oncotarget on June 25, 2025, titled "Hypoxia induced lipid droplet ...